For Physicians
Company
Support
Sign in
Register
Home
Hematology
Question
How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone?
1
1 Answers
Add Answer
Mednet Member
Medical Oncology · CompHealth
Venetoclax + CD19 or CD22 mab if available
Register
or
Sign In
to see full answer
How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone? | Mednet
